Chapter 19: Growth, Aging, and Cancer

Expansion of the organism is fueled by the proliferation of cells, the production of extracellular matrices, and the physical enlargement of individual cells, yet the overarching biological sensing of final dimensions remains largely enigmatic. Biological size is governed by dual regulatory tracks: the insulin/IGF-TOR complex, which synchronizes metabolic energy and nutrient intake with systemic expansion, and the Hippo signaling cascade, which interprets physical cues from adjacent cells to manage tissue-specific growth. Disruptions in these systems can result in clinical conditions such as gigantism or various forms of dwarfism, particularly through the regulation of epiphyseal growth plates in vertebrate limbs where molecules like Indian hedgehog and fibroblast growth factors dictate bone elongation. The text details the concept of allometry, describing how different body regions grow at varying rates, a process often modulated by negative feedback signals known as chalones, exemplified by myostatin’s role in limiting muscle mass. Regarding senescence, aging is presented as a combination of programmed developmental events—such as the erosion of telomeres and the accumulation of cell-cycle inhibitors like those at the INK4a/ARF locus—and stochastic macromolecular damage from oxidative stress. Research into the insulin pathway reveals its significant impact on longevity, demonstrating how caloric restriction and the activation of FoxO transcription factors can enhance cellular repair and extend the lifespan of diverse species. Finally, cancer is characterized as a fundamental breakdown of developmental growth boundaries, occurring when a single cell lineage accumulates mutations that grant it autonomy from systemic inhibitors. This malignant progression involves the activation of oncogenes such as Ras and Myc, the silencing of tumor suppressors like p53 and Rb, and the misappropriation of developmental mechanisms like the epithelial-to-mesenchymal transition to enable invasive metastasis and the recruitment of new blood vessels.